Lone Star Tick Spreads to 30 Countries, Driving Severe Red-Meat Allergy
Updated
Updated · WUFT · Jul 1
Lone Star Tick Spreads to 30 Countries, Driving Severe Red-Meat Allergy
1 articles · Updated · WUFT · Jul 1
Summary
Alpha-gal syndrome is now spreading in more than 30 countries on six continents, with the lone star tick expanding from the U.S. Southeast north to Maine and west to Oklahoma.
47% of people tested in a Missouri-Oklahoma-Arkansas hotspot had alpha-gal antibodies, a spread Bilger linked to warmer, wetter climates, reforestation, suburban edge habitats and a U.S. deer population of about 36 million.
The syndrome can trigger delayed but severe reactions—from hives and stomach distress to anaphylaxis—and can be set off by trace mammal products in dairy, gelatin capsules, heparin, skin creams and other medical or consumer goods.
Diagnosis has lagged: a 2017 study found only 1 in 10 cases correctly identified, with a median diagnosis time of 7 years; there is no cure, though EpiPens and the allergy drug Xolair can help manage reactions.
Control options remain limited, but Bilger said permethrin-treated clothing is the most practical personal defense while some communities, including Martha's Vineyard, are weighing large deer culls to cut tick numbers.
As a meat allergy spreads across continents, can new government programs halt the lone star tick's relentless advance?
With 450,000 Americans now affected, is the tick-borne red meat allergy becoming the next public health crisis?
Alpha-gal Syndrome in America: The Rapid Rise, Hidden Dangers, and Urgent Need for Awareness as 450,000+ Face Tick-Borne Meat Allergy
Overview
Alpha-gal Syndrome (AGS) is a potentially life-threatening allergy to meat, triggered by tick bites. Scientists have observed a clear rise in AGS cases, making it an increasingly significant public health concern. However, many medical professionals remain largely unaware of AGS, which leads to delayed diagnoses and prolonged suffering for those affected. This lack of awareness is highlighted by a recent survey showing only a quarter of doctors had heard of AGS. As a result, individuals often endure years of symptoms before receiving proper diagnosis and care, underscoring the urgent need for better education and awareness among healthcare providers.